---
$id: https://graph.org.ai/products/commodity/51141535
$type: Product
source: UNSPSC
code: "51141535"
title: "Cabergoline"
class: "51141500"
classTitle: "Anticonvulsants"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cabergoline

**UNSPSC Code**: 51141535
**Class**: [Anticonvulsants](Anticonvulsants.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula C26H37N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LL60K9J05T, chemically known as ergoline-8-carboxamide, n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)- but generally known as cabergoline, which bears US NIH Compound Identifier 54746. Cabergoline most often comes in base and diphosphate forms. European Medicines Agency schedules Cabergoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06041MIG. The term CABERGOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules cabergoline in its Anatomical Therapeutic Chemical (ATC) Classification. CABERGOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cabergoline under HS 29396900 and SITC 54146. As of Q4 2014, CABERGOLINE remains the US FDA Preferred Term for this commodity. Cabergoline bears US NLM identifiers UMLS ID C0107994 and NCI Concept Code C47428. SMILES: O=C(N(CCCN(C)C)C(=O)NCC)C1CC2C(N(C1)CC=C)CC1C3C2CCCC3[NH]C1.

